ALIM
Alimera Sciences, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website alimerasciences.com
- Employees(FY) 150
- ISIN US0162592028
Performance
-5.33%
1W
-10.61%
1M
-6.43%
3M
+5.26%
6M
-25.93%
YTD
+55.34%
1Y
Profile
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals. It operates through United States, internationally, and Operating Cost segments. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, clinics, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. Alimera Sciences, Inc. was incorporated in 2003 and is headquartered in Alpharetta, Georgia.
Technical Analysis of ALIM 2024-05-10
Overview:
In analyzing the technical indicators for ALIM over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and recommendations for potential in...
Recent News & Updates
- 2024-05-14 15:06
- 2024-05-13 23:53
- 2024-05-13 20:40
- 2024-05-13 20:40
- 2024-05-13 19:38
Alimera Sciences: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-13 19:30
Alimera Sciences Reports First Quarter 2024 Results(Globenewswire)
- 2024-05-06 20:00
- 2024-04-29 20:00
- 2024-03-19 20:00
- 2024-03-18 20:00
- 2024-03-07 21:05
- 2024-03-07 10:18
Q4 2023 Alimera Sciences Inc Earnings Call(Yahoo Finance)
- 2024-03-07 00:55
- 2024-03-06 23:52
- 2024-03-06 20:00
- 2024-03-06 19:11
Alimera Sciences: Q4 Earnings Snapshot(Yahoo Finance)
- 2024-03-06 18:30
- 2024-02-28 19:00
- 2024-02-07 19:00
- 2024-01-03 19:00
Alimera Completes Recruitment for the Synchronicity Study(Globenewswire)
- 2024-01-01 19:00
- 2023-12-11 18:30
- 2023-11-08 03:30
Alimera Appoints Maggie A. Pax to Its Board of Directors(Globenewswire)
- 2023-10-30 20:00
- 2023-10-26 21:26
- 2023-10-25 21:29
- 2023-10-25 20:30
- 2023-10-25 19:18
Alimera Sciences: Q3 Earnings Snapshot(Yahoo Finance)
- 2023-10-25 19:00
Alimera Sciences Reports Third Quarter 2023 Results(Globenewswire)
- 2023-10-15 20:00
Page 1 of 4
previousnext